image: Framework for noninvasive identification of diffuse large B cell lymphoma (DLBCL) poor-risk groups at different disease milestones is shown. This material relates to a paper that appeared in the Nov. 9, 2016, issue of Science Translational Medicine, published by AAAS. The paper, by F. Scherer at Stanford University, Department of Medicine in Stanford, CA, and colleagues was titled, "Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA." view more
Credit: F. Scherer <i>et al., Science Translational Medicine</i> (2016)